Host metabolism regulates growth and differentiation of Toxoplasma gondii

International Journal for Parasitology

Volumn 42, Issue 10, 2012, Pages 947-959

  Weilhammer, Dina R ^a   Iavarone, Anthony T ^b   Villegas, Eric N ^a,d   Brooks, George A ^a   Sinai, Anthony P ^c   Sha, William C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Akt; Bradyzoite differentiation; Glycolysis; Metabolism; Toxoplasma gondii

Indexed keywords

BAG 1 PROTEIN; LACTIC ACID; PROTEIN BCL 2; PROTEIN KINASE B; RED FLUORESCENT PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR REL; YELLOW FLUORESCENT PROTEIN;

GROWTH; HOST; METABOLISM; PARASITE; PATHOGEN; PROTOZOAN;

ARTICLE; BRADYZOITE; CONTROLLED STUDY; ENZYME INDUCTION; FLOW CYTOMETRY; GLYCOLYSIS; HOST CELL; HOST PARASITE INTERACTION; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLIC STRESS; METABOLITE; MICROBIAL GROWTH; NONHUMAN; PARASITE DEVELOPMENT; PARASITE IMMUNITY; PARASITE LOAD; PHENOTYPE; PROTEIN EXPRESSION; REINFECTION; SEROCONVERSION; SPECIES DIFFERENTIATION; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERO CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; TOXOPLASMA;

TOXOPLASMA GONDII;

EID: 84866495018     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.07.011     Document Type: Article

References (53)

1. Black M.W., Boothroyd J.C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 2000, 64:607-623.
2. Blader I.J., Manger I.D., Boothroyd J.C. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J. Biol. Chem. 2001, 276:24223-24231.
3. Blume M., Rodriguez-Contreras D., Landfear S., Fleige T., Soldati-Favre D., Lucius R., Gupta N. Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis. Proc. Natl. Acad. Sci. USA 2009, 106:12998-13003.
4. Bohne W., Heesemann J., Gross U. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect. Immun. 1993, 61:1141-1145.
5. Bohne W., Heesemann J., Gross U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 1994, 62:1761-1767.
6. Bohne W., Roos D.S. Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites. Mol. Biochem. Parasitol. 1997, 88:115-126.
7. Brooks G.A. Lactate shuttles in nature. Biochem. Soc. Trans. 2002, 30:258-264.
8. Coppens I., Joiner K.A. Parasite-host cell interactions in toxoplasmosis: new avenues for intervention?. Expert Rev. Mol. Med. 2001, 3:1-20.
9. Dando C., Schroeder E.R., Hunsaker L.A., Deck L.M., Royer R.E., Zhou X., Parmley S.F., Vander Jagt D.L. The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum. Mol. Biochem. Parasitol. 2001, 118:23-32.
10. Dubey J.P., Lindsay D.S., Speer C.A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 1998, 11:267-299.
11. Dzierszinski F., Popescu O., Toursel C., Slomianny C., Yahiaoui B., Tomavo S. The protozoan parasite Toxoplasma gondii expresses two functional plant-like glycolytic enzymes: implications for evolutionary origin of apicomplexans. J. Biol. Chem. 1999, 274:24888-24895.
12. Dzierszinski F., Nishi M., Ouko L., Roos D.S. Dynamics of Toxoplasma gondii differentiation. Eukaryotic Cell 2004, 3:992-1003.
13. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., Zhuang H., Cinalli R.M., Alavi A., Rudin C.M., Thompson C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
14. Ferreira da Silva M.D.F., Barbosa H.S., Gross U., Luder C.G.K. Stress-related and spontaneous stage differentiation ofToxoplasma gondii. Mol. BioSyst. 2008, 4:824-834.
15. Ferreira da Silva M.D.F., Takacs A.C., Barbosa H.S., Gross U., Luder C.G.K. Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. Int. J. Med. Microbiol. 2009, 299:381-388.
16. Ferreira da Silva M.D.F., Rodrigues R.M., Andrade E.F., Carvalho L., Gross U., Lüder C.G., Barbosa H.S. Spontaneous stage differentiation of mouse-virulent Toxoplasma gondii RH parasites in skeletal muscle cells: an ultrastructural evaluation. Mem. Inst. Oswaldo Cruz 2009, 104:196-200.
17. Fox B.A., Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 2002, 415:926-929.
18. Gross U., Bohne W., Soíte M., Dubremetz J.F. Developmental differentiation between tachyzoites and bradyzoites of Toxoplasma gondii. Parasitol. Today 1996, 12:30-33.
19. Gutmann I., Wahlefeld A. L-(+)-lactate determination with lactate dehydrogenase and NAD. Methods of Enzymatic Analysis 1974, 1464-1472. Academic, New York, NY, USA. H.U. Bergmeyer (Ed.).
20. Jones T.C., Bienz K.A., Erb P. In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect. Immun. 1986, 51:147-156.
21. Jones L.A., Alexander J., Roberts C.W. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol. 2006, 28:635-642.
22. Kim L., Denkers E.Y. Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis. J. Cell Sci. 2006, 119:2119-2126.
23. Latkany P. Ocular disease due to Toxoplasma gondii. Toxoplasma gondii the Model Apicomplexan: Perspectives and Methods 2007, 101-131. Academic Press, Elsevier, London, UK. L.M. Weiss, K. Kim (Eds.).
24. Lüder C.G., Giraldo-Velásquez M., Sendtner M., Gross U. Toxoplasma gondii in primary rat CNS Cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp. Parasitol. 1999, 93:23-32.
25. Manger I.D., Hehl A., Parmley S., Sibley L.D., Marra M., Hillier L., Waterston R., Boothroyd J.C. Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes. Infect. Immun. 1998, 66:1632-1637.
26. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
27. Nelson M.M., Jones A.R., Carmen J.C., Sinai A.P., Burchmore R., Wastling J.M. Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect. Immun. 2008, 76:828-844.
28. Pavlides S., Whitaker-Menezes D., Castello-Cros R., Flomenberg N., Witkiewicz A.K., Frank P.G., Casimiro M.C., Wang C., Fortina P., Addya S., Pestell R.G., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8:3984-4001.
29. Poellinger L., Johnson R.S. HIF-1 and hypoxic response: the plot thickens. Curr. Opin. Genet. Dev. 2004, 14:81-85.
30. Polonais V., Soldati-Favre D. Versatility in the acquisition of energy and carbon sources by the Apicomplexa. Biol. Cell 2010, 102:435-445.
31. Pomel S., Luk F.C.Y., Beckers C.J.M. Host cell egress and invasion induce marked relocations of glycolytic enzymes in Toxoplasma gondii tachyzoites. PLoS Pathog. 2008, 4:e1000188.
32. Radke J.R., Guerini M.N., Jerome M., White M.W. A change in the premitotic period of the cell cycle is associated with bradyzoite differentiation in Toxoplasma gondii. Mol. Biochem. Parasitol. 2003, 131:119-127.
33. Radke J.R., Donald R.G., Eibs A., Jerome M.E., Behnke M.S., Liberator P., White M.W. Changes in the expression of human cell division Autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog. 2006, 2:e105.
34. Rathmell J.C., Fox C.J., Plas D.R., Hammerman P.S., Cinalli R.M., Thompson C.B. Akt-directed glucose metabolism can prevent bax conformation change and promote growth factor-independent survival. Mol. Cell Biol. 2003, 23:7315-7328.
35. Richardson R.S., Noyszewski E.A., Leigh J.S., Wagner P.D. Lactate efflux from exercising human skeletal muscle: role of intracellular PO2. J. Appl. Physiol. 1998, 85:627-634.
36. Roos D.S., Donald R.G., Morrissette N.S., Moulton A.L. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol. 1994, 45:27-63.
37. Scharton-Kersten T., Wynn T.A., Denkers E.Y., Bala S., Grunvald E., Hieny S., Gazzinelli R.T., Sher A. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 1996, 157:4045-4054.
38. Scharton-Kersten T.M., Yap G., Magram J., Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 1997, 185:1261-1273.
39. Sibley L.D. Toxoplasma gondii: perfecting an intracellular life style. Traffic 2003, 4:581-586.
40. Sinai A.P. Biogenesis of and activities at the Toxoplasma gondii parasitophorous vacuole membrane. Subcell. Biochem. 2008, 47:155-164.
41. Skariah S., McIntyre M., Mordue D. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol. Res. 2010, 107:253-260.
42. Soete M., Camus D., Dubrametz J.F. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp. Parasitol. 1994, 78:361-370.
43. Spear W., Chan D., Coppens I., Johnson R.S., Giaccia A., Blader I.J. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiol. 2006, 8:339-352.
44. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518.
45. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 2000, 30:1217-1258.
46. Tomavo S., Boothroyd J.C. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii. Int. J. Parasitol. 1995, 25:1293-1299.
47. Tomavo S. The differential expression of multiple isoenzyme forms during stage conversion of Toxoplasma gondii: an adaptive developmental strategy. Int. J Parasitol. 2001, 31:1023-1031.
48. Wang Y., Weiss L.M., Orlofsky A. Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J. Biol. Chem. 2009, 284:1694-1701.
49. Wang Y., Karnataki A., Parsons M., Weiss L.M., Orlofsky A. 3-Methyladenine blocks Toxoplasma gondii division prior to centrosome replication. Mol. Biochem. Parasitol. 2010, 173:142-153.
50. Watson J.V., Chambers S.H., Smith P.J. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 1987, 8:1-8.
51. Weiss L.M., Laplace D., Takvorian P.M., Tanowitz H.B., Cali A., Wittner M. A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J. Eukaryot. Microbiol. 1995, 42:150-157.
52. Winkler B.S. Glycolytic and oxidative metabolism in relation to retinal function. J. Gen. Physiol. 1981, 77:667-692.
53. Yang S., Parmley S.F. Toxoplasma gondii expresses two distinct lactate dehydrogenase homologous genes during its life cycle in intermediate hosts. Gene 1997, 184:1-12.